Finally, we will discuss how current pharmacological approaches utilize MHC II and physiological functions of macrophages and microglia, underscoring some special interactions, in particular HLA-DRB alleles, and systemize applied and innovative strategies to refine therapeutic interventions in MS. Here, HLA-DRB1 is linked to myeloid sarcoma.